Tettero, Jesse M., Lok Lam Ngai, Costa Bachas, Dimitri A. Breems, Thomas Fischer, Bjorn T. Gjertsen, Patrycja Gradowska, Laimonas Griskevicius, Jeroen J.W.M. Janssen, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter J.M. Valk, Bob Löwenberg, Gert J. Ossenkoppele, and Jacqueline Cloos. 2023. “Measurable Residual Disease-Guided Therapy in Intermediate-Risk Acute Myeloid Leukemia Patients Is a Valuable Strategy in Reducing Allogeneic Transplantation Without Negatively Affecting Survival”. Haematologica 108 (10). Pavia, Italy, 2794-98. https://doi.org/10.3324/haematol.2022.282639.